[
  {
    "ts": null,
    "headline": "Gilead’s HIV Treatments Could Face Headwinds. Why the Stock Will Still Rise.",
    "summary": "Gilead Sciences  stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says.  Analysts led by Geoff Meacham reiterated a Buy rating on the shares with a $125 price target in a note Wednesday.  With Gilead up 1.2% to $109.23 on Wednesday, the price target suggests potential upside of 14%.",
    "url": "https://finnhub.io/api/news?id=0f6c0b0e195b590471da04344a4333cd95dda6e4e7ec441563448a84b79492c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743007500,
      "headline": "Gilead’s HIV Treatments Could Face Headwinds. Why the Stock Will Still Rise.",
      "id": 133462147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences  stock has room to climb, and investors shouldn’t overlook the company’s impressive record in navigating HIV policy, Citi Research says.  Analysts led by Geoff Meacham reiterated a Buy rating on the shares with a $125 price target in a note Wednesday.  With Gilead up 1.2% to $109.23 on Wednesday, the price target suggests potential upside of 14%.",
      "url": "https://finnhub.io/api/news?id=0f6c0b0e195b590471da04344a4333cd95dda6e4e7ec441563448a84b79492c5"
    }
  },
  {
    "ts": null,
    "headline": "Are Medical Stocks Lagging  Gilead Sciences (GILD) This Year?",
    "summary": "Here is how Gilead Sciences (GILD) and AngioDynamics (ANGO) have performed compared to their sector so far this year.",
    "url": "https://finnhub.io/api/news?id=b3f241b6a1e0fc549cb13d8b5b36c7ba0273f79e9a255d089d5a51fe14485133",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742996411,
      "headline": "Are Medical Stocks Lagging  Gilead Sciences (GILD) This Year?",
      "id": 133457273,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Here is how Gilead Sciences (GILD) and AngioDynamics (ANGO) have performed compared to their sector so far this year.",
      "url": "https://finnhub.io/api/news?id=b3f241b6a1e0fc549cb13d8b5b36c7ba0273f79e9a255d089d5a51fe14485133"
    }
  }
]